Primary Research on Chinese Medicine Treatment of Androgen-Independent Prostate Cancer

被引：0
|
作者：
张蜀武 [1 ]
周仕轶 [1 ]
邵继春 [1 ]
曲晓伟 [1 ]
机构：
[1] Chengdu University of Traditional Chinese Medicine
来源：
Chinese Journal of Integrative Medicine | 2009年 / 15卷 / 03期
关键词：
In; RHD; Primary Research on Chinese Medicine Treatment of Androgen-Independent Prostate Cancer;
D O I：
暂无
中图分类号：
R737.25 [前列腺肿瘤];
学科分类号：
100214 ;
摘要：
Prostate cancer(PC) is a common malignant tumor in the male seniors,and its incidence has been ascending in China in recent years. Over 80%of the patients are diagnosed as being in the late stage and lose the opportunity of radical operation because of its early stage metastasis. Endocrinotherapy is regarded
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [41] Androgen-independent prostate cancer progression in the TRAMP model
    Gingrich, JR
    Barrios, RJ
    Kattan, MW
    Nahm, HS
    Finegold, MJ
    Greenberg, NM
    CANCER RESEARCH, 1997, 57 (21) : 4687 - 4691
  • [42] A new weapon against androgen-independent prostate cancer
    Kent, H
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1999, 161 (04) : 364 - 364
  • [43] New approaches to treatment of androgen-independent prostate cancer based on peptide analogs
    Schally, AV
    CURRENT ADVANCES IN ANDROLOGY, 1997, : 81 - 87
  • [44] Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer
    Edwards, J
    Krishna, NS
    Mukherjee, R
    Watters, AD
    Underwood, MA
    Bartlett, JMS
    BJU INTERNATIONAL, 2001, 88 (06) : 633 - 637
  • [45] Lef1 Expression in Androgen-Independent Prostate Cancer
    Zhang, M.
    Li, Y. R.
    Wang, L. G.
    Melamed, J.
    Liu, X. M.
    Wei, J. J.
    Peng, Y.
    Pellicer, A.
    Garabedian, M. J.
    Ferrari, A.
    Lee, P.
    LABORATORY INVESTIGATION, 2009, 89 : 203A - 203A
  • [46] Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer
    Altundag, K
    Altundag, O
    Morandi, P
    Gunduz, M
    UROLOGY, 2005, 65 (01) : 211 - 212
  • [47] Thalidomide/estramustme/pacfitaxel in metastatic androgen-independent prostate cancer
    Mathew, Paul
    Logothetis, Christopher J.
    Dieringer, Pauline Y.
    Chen, Isan
    Pagliaro, Lance C.
    Bekele, Benjamin N.
    Zhou, Man
    Daliani, Danai D.
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 144 - 149
  • [48] Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway
    Mellado, Begona
    Codony, Jordi
    Ribal, Maria Jose
    Visa, Laura
    Gascon, Pere
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01): : 5 - 10
  • [49] Functional characterization of mutant androgen receptors from androgen-independent prostate cancer
    Fenton, MA
    Shuster, TD
    Fertig, AM
    Taplin, ME
    Kolvenbag, G
    Bubley, GJ
    Balk, SP
    CLINICAL CANCER RESEARCH, 1997, 3 (08) : 1383 - 1388
  • [50] Lef1 Expression in Androgen-Independent Prostate Cancer
    Zhang, M.
    Li, Y. R.
    Wang, L. G.
    Melamed, J.
    Liu, X. M.
    Wei, J. J.
    Peng, Y.
    Pellicer, A.
    Garabedian, M. J.
    Ferrari, A.
    Lee, P.
    MODERN PATHOLOGY, 2009, 22 : 203A - 203A
12345